Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker 
function

Deutschmeyer, Verena; Breuer, Janina; Walesch, Sara K.; Sokol, Anna M.; Graumann, Johannes; Bartkuhn, Marek; Boettger, Thomas; Rossbach, Oliver; Richter, Antje M.

doi:10.1186/s13148-019-0774-2

Lokale TagsFreigabegeschichteDetailsÜbersicht

Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function

Deutschmeyer, V., Breuer, J., Walesch, S. K., Sokol, A. M., Graumann, J., Bartkuhn, M., et al. (2019). Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function. CLINICAL EPIGENETICS, 11(1): 182. doi:10.1186/s13148-019-0774-2.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/21.11116/0000-0006-AF11-2 Versions-Permalink: https://hdl.handle.net/21.11116/0000-0006-AF12-1

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Deutschmeyer, Verena, Autor
Breuer, Janina, Autor
Walesch, Sara K., Autor
Sokol, Anna M.¹, Autor
Graumann, Johannes¹, Autor
Bartkuhn, Marek, Autor
Boettger, Thomas², Autor
Rossbach, Oliver, Autor
Richter, Antje M.², Autor

Affiliations:
1Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Max Planck Society, ou_2591705
2Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society, ou_2591695